Clinical research in developing countries: recent moral arguments.
During the 1990s, bioethicists raised questions about certain clinical trials conducted in developing countries. These inquiries led to revisions in the Declaration of Helsinki and recommendations from the US National Bioethics Advisory Commission. This article raises doubts about the original questions and subsequent recommendations. It is possible that impractical solutions have been proposed for nonexistent ethical problems.
Lackey
Douglas P
DP
Department of Philosophy, Baruch College and the Graduate Center, City University of New York, New York, NY, U.S.A. dlackey@gc.cuny.edu
D026683:Advisory Committees / Q000592:standards; D002986:Clinical Trials as Topic / Q000941:ethics* / Q000592:standards; D003906:Developing Countries; D026690:Ethics, Clinical; D004992:Ethics, Medical; D006381:Helsinki Declaration; D006801:Humans; D007258:Informed Consent; D012106:Research / Q000592:standards*; D014481:United States
Biomedical and Behavioral Research